The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Murphy Sean since 2020.
This trader's CIK number is 1685042.
At the time of last reporting, Murphy Sean was the Chief Manuf, Strategy&Bus Dev. of Trisalus Life Sciences, Inc.. (stock ticker symbol TLSI).
Also see all insider trading activities at Trisalus Life Sciences, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | TLSI | 30,000 | $157,200 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | PSTX | 10,000 | $160,000 | 0 | $0 | 0 | $0 |
1. Trisalus Life Sciences, Inc. (TLSI)
2. Poseida Therapeutics, Inc. (PSTX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-01-28 | TLSI | Buy | 15,000 | 5.17 | 77,550 |
2025-01-27 | TLSI | Buy | 15,000 | 5.31 | 79,650 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-07-14 | PSTX | Buy | 10,000 | 16.00 | 160,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murphy Sean (Chief Manuf, Strategy&Bus Dev. of Trisalus Life Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.